News
ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor) approved in the EU for people with CF 6 years and older with at least one non-class I mutation in the CFTR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback